Fluorouracil Topical Clinical Trials

• A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women
  ClinicalTrials.gov Identifier: NCT00000758 - Completed
  HIV Infections; Cervix, Dysplasia
  
• Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00349076 - Recruiting
  Rectal Neoplasms
  
• Does Topical Steroid Treatment Impair the Adrenal Function?
  ClinicalTrials.gov Identifier: NCT00476489 - Recruiting
  Hypothalamus-Pituitary-Adrenal Axis Assessement; Topical Steroid Therapy in Chronic Skin Diseases
  
• DAVANAT Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00110721 - Active, not recruiting
  Colorectal Cancer
  
• A Study of the Safety, Pharmacokinetics of 5 Fluorouracil, and Anti-Tumor Activity of ADH300004 and 5 Fluorouracil Administered Orally to Subjects With Incurable Solid Tumors.
  ClinicalTrials.gov Identifier: NCT00264472 - Recruiting
  Neoplasms
  
• High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
  ClinicalTrials.gov Identifier: NCT00004150 - Active, not recruiting
  stage III colon cancer; adenocarcinoma of the colon; mucinous adenocarcinoma of the colon
  
• Oblimersen, Cisplatin, and Fluorouracil in Treating Patients With Advanced Esophageal, Gastroesophageal Junction, or Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00064259 - Active, not recruiting
  Esophageal Cancer; Gastric Cancer
  
• A study of capecitabine in combo w/ XELOX vs fluorouracil/leucovorin w/ oxaliplatin (FOLFOX4) as treatment for pts w/ metastatic colorectal cancer, who have received prior treatment w/ CPT-11 in combo w/ fluorouracil/leucovorin
  ClinicalTrials.gov Identifier: NCT00069108 - Active, not recruiting
  Colorectal Cancer; Metastases
  
• Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00024141 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00004206 - Active, not recruiting
  recurrent ovarian epithelial cancer
  
• Fluorouracil Plus Ethynyluracil in Treating Patients With Advanced Colorectal Cancer That Has Not Responded to Fluorouracil
  ClinicalTrials.gov Identifier: NCT00003254 - Active, not recruiting
  recurrent colon cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Comparison of the Efficacy of Topical Ibuprofen to Oral Ibuprofen in Adolescent Athletes
  ClinicalTrials.gov Identifier: NCT00567528 - Recruiting
  Soft Tissue Injuries; Comparison of Topical and Oral Ibuprofen
  
• Study to Compare the Acne Relapse Rate of Oral Minocycline to Oral Minocycline in Combination With Topical Tretinoin, Followed by Topical Tretinoin Alone
  ClinicalTrials.gov Identifier: NCT00240513 - Recruiting
  Acne Vulgaris
  
• Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
  ClinicalTrials.gov Identifier: NCT00091312 - Active, not recruiting
  stage II colon cancer; adenocarcinoma of the colon
  
• Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00024427 - Active, not recruiting
  adenocarcinoma of the pancreas; Drug Toxicity; Pancreatic Cancer
  
• Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach
  ClinicalTrials.gov Identifier: NCT00004233 - Active, not recruiting
  Gastric Cancer; Esophageal Cancer; Adenocarcinoma of the Esophagus
  
• Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00005871 - Active, not recruiting
  recurrent pancreatic cancer; adenocarcinoma of the pancreas
  
• Capecitabine Compared With Fluorouracil Plus Leucovorin in Treating Patients Who Have Undergone Surgery for Stage III Colon Cancer
  ClinicalTrials.gov Identifier: NCT00009737 - Active, not recruiting
  stage III colon cancer
  
• Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00033735 - Active, not recruiting
  recurrent pancreatic cancer; duct cell adenocarcinoma of the pancreas
  
• Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00075738 - Active, not recruiting
  stage IV esophageal cancer; recurrent esophageal cancer
  
• Interferon alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00053820 - Active, not recruiting
  Stage IV Renal Cell Cancer
  
• Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00103103 - Active, not recruiting
  recurrent gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
  
• Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005608 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon
  ClinicalTrials.gov Identifier: NCT00085163 - Active, not recruiting
  adenocarcinoma of the colon; stage III colon cancer
  
• Topical Amethocaine Gel for Intramuscular Injection in Term Neonates
  ClinicalTrials.gov Identifier: NCT00267111 - Active, not recruiting
  Pain
  
• Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003730 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00096070 - Active, not recruiting
  adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer
  
• Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00023959 - Active, not recruiting
  Head and Neck Cancer
  
• Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer
  ClinicalTrials.gov Identifier: NCT00083109 - Active, not recruiting
  recurrent renal cell cancer; Stage IV Renal Cell Cancer
  
• An Imaging Trial of the Distribution of Topical Gel Formulations in the Human Vagina
  ClinicalTrials.gov Identifier: NCT00214747 - Active, not recruiting
  HIV Infections
  
• Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination
  ClinicalTrials.gov Identifier: NCT00507091 - Active, not recruiting
  Metastatic; Colorectal; Adenocarcinoma
  
• Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant
  ClinicalTrials.gov Identifier: NCT00082706 - Recruiting
  Bladder Cancer; Urethral Cancer
  
• Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss
  ClinicalTrials.gov Identifier: NCT00418730 - Active, not recruiting
  Androgenetic Alopecia
  
• A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel
  ClinicalTrials.gov Identifier: NCT00427050 - Active, not recruiting
  Actinic Keratoses
  
• Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00080951 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum
  
• An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00270543 - Not yet recruiting
  Stomach Neoplasms
  
• Interleukin-2, Interferon alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00053807 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer
  
• Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
  ClinicalTrials.gov Identifier: NCT00005586 - Active, not recruiting
  stage II colon cancer; stage III colon cancer; stage II rectal cancer; stage III rectal cancer
  
• A Phase 4 Trial Assessing CLOBEX Spray, 0.05% When Used as Monotherapy or as Add-on Therapy to Existing Systemic or Topical Anti-Psoriatic Agents.
  ClinicalTrials.gov Identifier: NCT00437216 - Active, not recruiting
  Psoriasis
  
• Ketoprofen Topical Patch, 20% in the Treatment of Pain Associated With Osteoarthritis Flare of the Knee
  ClinicalTrials.gov Identifier: NCT00365586 - Active, not recruiting
  Osteoarthritis
  
• Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
  ClinicalTrials.gov Identifier: NCT00096278 - Active, not recruiting
  adenocarcinoma of the colon; stage II colon cancer; stage III colon cancer
  
• Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin
  ClinicalTrials.gov Identifier: NCT00004005 - Active, not recruiting
  adult solid tumor; carcinoma of unknown primary; childhood solid tumor; Colon Cancer; Rectal Cancer
  
• Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00026273 - Active, not recruiting
  adenocarcinoma of the rectum; stage III colon cancer; stage III rectal cancer; adenocarcinoma of the colon
  
• Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00016042 - Active, not recruiting
  recurrent colon cancer; Stage IV Renal Cell Cancer; Stage IV rectal cancer; recurrent rectal cancer; recurrent renal cell cancer; ...
  
• Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00016952 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ...
  
• Efficacy Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail
  ClinicalTrials.gov Identifier: NCT00443820 - Active, not recruiting
  Onychomycosis
  
• Efficacy, Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail
  ClinicalTrials.gov Identifier: NCT00443898 - Active, not recruiting
  Onychomycosis
  
• Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer
  ClinicalTrials.gov Identifier: NCT00004931 - Active, not recruiting
  stage III colon cancer; stage II colon cancer
  
• Comparison of Adjuvant Chemotherapy Regimens in Treating Patients With Stage II or Stage III Rectal Cancer Who Are Receiving Radiation Therapy and Fluorouracil Before or After Surgery
  ClinicalTrials.gov Identifier: NCT00068692 - Active, not recruiting
  adenocarcinoma of the rectum; stage II rectal cancer; stage III rectal cancer
  
• Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00075595 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ...
  
• Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
  ClinicalTrials.gov Identifier: NCT00433485 - Active, not recruiting
  Neoplastic Syndrome; Non-Melanomatous Skin Cancer
  
• A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the Hand
  ClinicalTrials.gov Identifier: NCT00544297 - Active, not recruiting
  Actinic Keratosis
  
• Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003029 - Active, not recruiting
  stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Flavopiridol, Oxaliplatin, Fluorouracil, and Leucovorin in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00080990 - Recruiting
  unspecified adult solid tumor, protocol specific
  
• Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix
  ClinicalTrials.gov Identifier: NCT00003078 - Active, not recruiting
  cervical squamous cell carcinoma; cervical adenocarcinoma; stage IIB cervical cancer; stage III cervical cancer; ...
  
• Safety and Efficacy Trial of the Use of A-007 Topical Gel in the Treatment of HSIL of the Cervix
  ClinicalTrials.gov Identifier: NCT00285207 - Active, not recruiting
  Cervical Intraepithelial Neoplasia; Uterine Cervical Dysplasia
  
• Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for Cancer
  ClinicalTrials.gov Identifier: NCT00362986 - Active, not recruiting
  Dermatologic Complications; Unspecified Adult Solid Tumor, Protocol Specific
  
• Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00002842 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; liver metastases
  
• Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00084773 - Active, not recruiting
  recurrent rectal cancer; stage II rectal cancer; stage III rectal cancer; adenocarcinoma of the rectum
  
• Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003175 - Active, not recruiting
  recurrent transitional cell cancer of the renal pelvis and ureter; recurrent urethral cancer; childhood kidney/urinary cancer; ...
  
• Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00006112 - Active, not recruiting
  adenocarcinoma of the rectum; childhood gastrointestinal cancer; peritoneal cavity cancer; Stage IV rectal cancer; carcinoma of the appendix; ...
  
• Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
  ClinicalTrials.gov Identifier: NCT00022139 - Active, not recruiting
  stage III gastric cancer; stage II esophageal cancer; stage III esophageal cancer; adenocarcinoma of the stomach; ...
  
• Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00072553 - Active, not recruiting
  Stage IV rectal cancer; stage IV colon cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent rectal cancer; ...
  
• Efficacy, Safety and Tolerability of Topical 10% Terbinafine Hydrogen Chloride Versus 5% Amorolfine Nail Lacquer in Patients With Mild to Moderate Toenail Onychomycosis
  ClinicalTrials.gov Identifier: NCT00459537 - Active, not recruiting
  Onychomycosis
  
• Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00062426 - Active, not recruiting
  adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent colon cancer; stage IV colon cancer; recurrent rectal cancer; ...
  
• Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00070213 - Recruiting
  Colon Cancer; Quality of Life; Rectal Cancer
  
• Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00016198 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Efficacy of a New Topical Anesthetic
  ClinicalTrials.gov Identifier: NCT00562211 - Recruiting
  Pain
  
• Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00098982 - Active, not recruiting
  stage III colon cancer; stage IV colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
  
• Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00004252 - Active, not recruiting
  recurrent colon cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; Quality of Life; adenocarcinoma of the colon
  
• Combination Chemotherapy in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00003331 - Active, not recruiting
  Cancer
  
• Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Ankle Sprain or Strain
  ClinicalTrials.gov Identifier: NCT00351104 - Active, not recruiting
  Sprain; Strain
  
• Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis
  ClinicalTrials.gov Identifier: NCT00352625 - Active, not recruiting
  Tendonitis; Bursitis
  
• Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study
  ClinicalTrials.gov Identifier: NCT00443105 - Active, not recruiting
  Allergic Conjunctivitis
  
• Fluorouracil and Leucovorin Plus Either Irinotecan or Oxaliplatin With or Without Cetuximab in Treating Patients With Previously Untreated Metastatic Adenocarcinoma of the Colon or Rectum
  ClinicalTrials.gov Identifier: NCT00077233 - Active, not recruiting
  adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent colon cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Combination Chemotherapy in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00003956 - Active, not recruiting
  Cancer
  
• Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00010062 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer
  
• A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris
  ClinicalTrials.gov Identifier: NCT00421993 - Active, not recruiting
  Acne Vulgaris
  
• Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00423007 - Active, not recruiting
  Allergic Conjunctivitis
  
• Study of a New Dressing for Use With Topical Medications
  ClinicalTrials.gov Identifier: NCT00234728 - Recruiting
  Psoriasis
  
• Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas
  ClinicalTrials.gov Identifier: NCT00079365 - Active, not recruiting
  adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Topical Agent for Treatment of Red Skin
  ClinicalTrials.gov Identifier: NCT00279890 - Active, not recruiting
  Rosacea; Bilaterally Symmetric Red Skin on Cheeks
  
• Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003873 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer
  ClinicalTrials.gov Identifier: NCT00068744 - Active, not recruiting
  squamous cell carcinoma of the anus; stage II anal cancer; stage IIIA anal cancer; stage IIIB anal cancer
  
• S-1 and Cisplatin or Fluorouracil and Cisplatin in Treating Patients With Locally Advanced or Metastatic Gastric Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00128609 - Recruiting
  stage IV gastric cancer; recurrent gastric cancer; adenocarcinoma of the stomach
  
• Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00004885 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; Quality of Life; ...
  
• Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora
  ClinicalTrials.gov Identifier: NCT00312338 - Active, not recruiting
  Bacterial Conjunctivitis
  
• FLOX in Combination with Cetuximab in First-Line Treatment of Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00145314 - Recruiting
  Metastatic Colorectal Cancer
  
• Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer
  ClinicalTrials.gov Identifier: NCT00425152 - Active, not recruiting
  Colorectal Cancer
  
• Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00433420 - Active, not recruiting
  Breast Cancer
  
• Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies
  ClinicalTrials.gov Identifier: NCT00215501 - Active, not recruiting
  Solid Tumor
  
• Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00336960 - Active, not recruiting
  Colorectal Cancer
  
• A Study of the Effect of Time on Topical Anesthetic Efficacy.
  ClinicalTrials.gov Identifier: NCT00353041 - Recruiting
  Pain
  
• New Topical Treatment for Continued Pain After Shingles
  ClinicalTrials.gov Identifier: NCT00566904 - Recruiting
  Postherpetic Neuralgia
  
• Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003216 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer
  
• Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00465699 - Recruiting
  Eczema
  
• A Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factor for Induction of Healing of Diabetic Foot Ulcers
  ClinicalTrials.gov Identifier: NCT00351767 - Active, not recruiting
  Diabetic Foot Ulcers
  
• Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva
  ClinicalTrials.gov Identifier: NCT00504023 - Recruiting
  Vulvar Cancer
  
• Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00275119 - Active, not recruiting
  Pancreatic Cancer
  
• Combination Chemotherapy in Treating Patients With Merkel Cell Cancer
  ClinicalTrials.gov Identifier: NCT00003549 - Active, not recruiting
  neuroendocrine carcinoma of the skin